Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 10Brain Neoplasms 8Myelodysplastic Syndromes 7Neoplasm Metastasis 6Leukemia, Lymphocytic, Chronic, B-Cell 6Glioblastoma 6Recurrence 5Lymphoma 5Glioma 5Sarcoma 4Leukemia 4Head and Neck Neoplasms 4Colorectal Neoplasms 4Astrocytoma 4Ovarian Neoplasms 3Neoplasms 3Lymphoma, Large B-Cell, Diffuse 3Breast Neoplasms 3Uveal Melanoma 2Uterine Cervical Neoplasms 2Thyroid Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Pancreatic Neoplasms 2Neoplasms, Neuroepithelial 2Nasopharyngeal Carcinoma 2Mouth Neoplasms 2Melanoma 2Medulloblastoma 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2

Interventions

Cyclophosphamide 63fludarabine phosphate 40Peripheral Blood Stem Cell Transplantation 34Vincristine 30Methotrexate 30Etoposide 29Cytarabine 28Dexamethasone 27Whole-Body Irradiation 25Doxorubicin 25Mycophenolic Acid 23Prednisone 22Tacrolimus 21Filgrastim 21Busulfan 19Antilymphocyte Serum 18venetoclax 17nelarabine 17Cyclosporine 17Calcium Dobesilate 17merphos 15Rituximab 14Radiotherapy 14Methylprednisolone 13Bortezomib 13pegaspargase 12dexamethasone acetate 11dexamethasone 21-phosphate 11Melphalan 11prednylidene 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × Valproic Acid × Clear all
NCT00854581 2018-04-17

Zidovudine, Interferon Alfa-2b, PEG-Interferon Alfa-2b in Patients With HTLV-I Associated Adult T-Cell Leukemia/Lymphoma

University of Miami

Phase 4 Terminated
13 enrolled 15 charts
LymphoidOther hematologic neoplasmOther neoplasm

Lymphoma, Precancerous Conditions, HTLV-I Infections, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡